Cite
HARVARD Citation
Spiera, R. et al. (2011). Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial. Annals of the rheumatic diseases. 70 (6), pp. 1003-1009. [Online].